• Produto
    • Produto
    • Fornecedor
Avançado

Taiwanese University to Work with Danish Pharmaceutical Firm

Source: Taiwantrade | Updated: 15 June 2012

The university team has agreed to license selected intellectual property and transfer certain technology to Novo Nordisk A/S, a Danish-based pharmaceutical company for a total payment of US$ 13.3 million in case of a successful completion of the project.
In addition, Professor Ming-Shi Chang and Novo Nordisk A/S have established a 2-year research collaboration to further strengthen and possible expand the usages of an IL-20 antibody.
This medical discovery was published in the Journal of Experimental Medicine (JEM) and has drawn huge attention in the academic world and the biotechnology industry as well.

Recomendações

Loading ...

Recomendação para Pequenas Quantidades

Loading ...